Additionally, resveratrol used at different concentrations, detailed in Table 6, has been found to mitigate the adhesive, migratory, and invasive properties of cancer cells by simultaneously downregulating MMP-2 and MMP-9 and upregulating TIMP-1 and TIMP-2 in bladder cancer [129], prostate cancer [130], and thyroid carcinoma [131]. Here, MMP2 is linked to prostate cancer.